Resources for Care Providers - AIDS Institute Clinical Guidelines

HIV Care Provider Definitions

New York State Department of Health AIDS Institute, April 2017

Experienced HIV care provider: Practitioners who have been accorded HIV-Experienced Provider status by the American Academy of HIV Medicine (AAHIVM) or have met the HIV Medicine Association’s (HIVMA) definition of and experienced provider are eligible for designation as an HIV Experienced Provider in New York State.

Nurse practitioners and licensed midwives who provide clinical care to HIV-Infected individuals in collaboration with a physician may be considered HIV Experienced Providers provided that all other practice agreements are met (8 NYCRR 79-5:1; 10 NYCRR 85.36; 8 NYCRR 139-6900)

Physician assistants who provide clinical care to HIV-infected individuals under the supervision of an HIV Specialist physician may also be considered HIV Experienced Providers (10 NYCRR 94.2)

Expert HIV care provider: A provider with extensive experience in the management of complex patients with HIV.

All FDA-Approved HIV Medications

Updated September 13, 2018

Listed below are all FDA-approved HIV medications as of June 4, 2018, with links to the AIDSinfo drug database. For professionals, the links open the FDA label pages, and for consumers, the links open the AIDSinfo patient information pages. The list is organized by drug class, with individual drugs listed in alphabetical order. Combination drugs are also listed in alphabetical order.

Nucleoside Reverse Transcriptase Inhibitors (NRTIs): characteristics

Abacavir (ABC; Ziagen): FDA label | Patient info
Emtricitabine (FTC; Emtriva): FDA label | Patient info
Lamivudine (3TC; Epivir): FDA label | Patient info
Tenofovir Disoproxil Fumarate (TDF; Viread): FDA label | Patient info
Zidovudine (AZT, ZDV; Retrovir): FDA label | Patient info

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): characteristics

Doravirine (DOR; Pifeltro): FDA label | Patient info
Efavirenz (EFV; Sustiva): FDA label | Patient info
Etravirine (ETR; Intelence): FDA label | Patient info
Nevirapine (NVP; Viramune, Viramune XR [extended release]): FDA label | Patient info
Rilpivirine (RPV; Edurant): FDA label | Patient info

Protease Inhibitors (PIs): characteristics

Atazanavir (ATV; Reyataz): FDA label | Patient info
Darunavir (DRV; Prezista): FDA label | Patient info
Fosamprenavir (FPV; Lexiva): FDA label | Patient info
Ritonavir (RTV; Norvir): FDA label | Patient info
Saquinavir (SQV; Invirase): FDA label | Patient info
Tipranavir (TPV; Aptivus): FDA label | Patient info

Fusion Inhibitor: characteristics

Enfuvirtide (T-20; Fuzeon): FDA label | Patient info

CCR5 Antagonist: characteristics

Maraviroc (MVC; Selzentry): FDA label | Patient info

Integrase Inhibitors (INSTIs): characteristics

Dolutegravir (DTG; Tivicay): FDA label | Patient info
Raltegravir (RAL; Isentress, Isentress HD): FDA label | Patient info

Post-Attachment Inhibitor:

Ibalizumab (IBA; Trogarzo): FDA label | Patient info

Pharmacokinetic Enhancer:

Cobicistat (COBI; Tybost): FDA label | Patient info

Combination HIV Medications:

Abacavir/Lamivudine (ABC/3TC; Epzicom): FDA label | Patient info
Abacavir/Dolutegravir/Lamivudine (ABC/DTG/3TC; Triumeq): FDA label | Patient info
Abacavir/Lamivudine/Zidovudine (ABC/3TC/ZDV; Trizivir): FDA label | Patient info
Atazanavir/Cobicistat (ATV/COBI; Evotaz): FDA label | Patient info
Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate (BIC/FTC/TAF; Biktarvy): FDA label | Patient info
Darunavir/Cobicistat (DRV/COBI; Prezcobix): FDA label | Patient info
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alefenamide (DRV/COBI/FTC/TAF; Symtuza): FDA label | Patient info
Dolutegravir/Rilpivirine (DTG/RPV; Juluca): FDA label | Patient info
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF; Delstrigo): FDA label | Patient info
Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF; Atripla): FDA label | Patient info
Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate (EFV/3TC/TDF; Symfi, Symfi Lo): FDA label | Patient info
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (EVG/COBI/FTC/TAF; Genvoya): FDA label | Patient info
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate (EVG/COBI/FTC/TDF; Stribild): FDA label | Patient info
Emtricitabine/Rilpivirine/Tenofovir Alafenamide Fumarate (FTC/RPV/TAF; Odefsy): FDA label | Patient info
Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF; Complera): FDA label | Patient info
Emtricitabine/Tenofovir Alafenamide Fumarate (FTC/TAF; Descovy): FDA label | Patient info
Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF; Truvada): FDA label | Patient info
Lamivudine/Tenofovir Disoproxil Fumarate (3TC/TDF; Cimduo): FDA label | Patient info
Lamivudine/Zidovudine (3TC/ZDV; Combivir): FDA label | Patient info
Lopinavir/Ritonavir (LPV/r; Kaletra): FDA label | Patient info

ARV Drug Name Abbreviation Key


Abbreviation	Full Drug Name
3TC	lamivudine
ABC	abacavir
APV	amprenavir
ATV	atazanavir
ATV/c	atazanavir/cobicistat
ATV/r	atazanavir/ritonavir
AZT	zidovudine
BIC	bictegravir
COBI or c	cobicistat
DCV	daclatasvir
ddC	zalcitabine
DLV	delavirdine
DRV	darunavir
DRV/c	darunavir/cobicistat
DRV/r	darunavir/ritonavir
DTG	dolutegravir
EFV	efavirenz
EFV/TDF/FTC	efavirenz/tenofovir disoproxil fumarate/emtricitabine
ETR	etravirine
EVG/c	elvitegravir/cobicistat
EVG/c/TAF/FTC	elvitegravir/cobicistat/tenofovir alafenamide/emtricitabine
EVG/c/TDF/FTC	elvitegravir/cobicistat/tenofovir disoproxil fumarate/ emtricitabine
EVG/r	elvitegravir/ritonavir
FPV	fosamprenavir
FPV/r	fosamprenavir/ritonavir
FTC	emtricitabine
IBA	ibalizumab
LPV	lopinavir
LPV/r	lopinavir/ritonavir
MVC	maraviroc
NVP	nevirapine
PI/c	cobicistat-boosted protease inhibitor
PI/r	ritonavir-boosted protease inhibitor
RAL	raltegravir
RPV	rilpivirine
RTV	ritonavir
SQV	saquinavir
SQV/r	saquinavir/ritonavir
T-20	enfuvirtide
TAF	tenofovir alafenamide
TDF	tenofovir disoproxil fumarate
TPV	tipranavir
TPV/r	tipranavir/ritonavir
ZDV	zidovudine